Sustainability & Climate

With a $2M JobsOhio grant, Hartzell's new Innovation Center propels Ohio's aerospace legacy into the era of advanced air mobility and high-tech jobs.

A partnership between Kinko Optical and Beneq aims to scale AR waveguide production, tackling a key obstacle for the next generation of XR devices.

A push to simplify mortgage credit checks could raise rates and reduce access to loans, with a new study revealing the hidden financial risks for consumers.

A new subcontract for AI edge systems, backed by key industry investors, highlights a major shift toward real-time, autonomous intelligence on the battlefield.

Record storms and global events are disrupting travel. Your airline refund won't cover everything. Here’s how to protect your vacation investment.

A 14th-century Scottish castle is set for a modern makeover as MDJM LTD bets on turning the historic Fernie Castle into a major animation art gallery.

Steel giant Nucor announces a massive new share repurchase and its 212th straight dividend, signaling deep confidence in its future and the broader economy.

On a day of remembrance, Canada reaffirms its commitment to aviation safety, driven by past tragedies and emerging geopolitical threats.

A South Carolina community built around a working farm just won two of the nation's highest homebuilding awards, cementing the Agrihood as the future of living.

New data on leronlimab reveals striking long-term survival signals in heavily pretreated mTNBC patients, hinting at a new way to fight the disease.

Hair Cuttery Family of Brands is rolling out amika products in 500+ salons, a strategic move to meet demand for premium, inclusive haircare for all.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

India's largest newspaper group wins a top CSR award, but it's the citizen-led campaigns behind the win that reveal a new model for media's social impact.

With its NAD+ technology featured in Forbes, biotech brand Aramore is challenging marketing hype with scientific rigor and a vision for longevity.

ABLi Therapeutics reports its drug risvodetinib is the first to lower toxic alpha-synuclein levels in a Phase 2 trial, heralding a new era for patients.

enGene hits the road for key investor conferences, showcasing a promising non-viral gene therapy for a tough-to-treat bladder cancer. Will it succeed?

Following massive asset sales and billions in dividends, Array Digital reports surging tower revenue and an optimistic forecast for its new 5G future.

Stunning high-grade gold samples, including one at 250 g/t, prompt Yukon Metals to consolidate a historic mining area near Whitehorse.

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

A NJ practice is targeting the hidden crisis of eating disorders in men and athletes, offering specialized virtual care to break down stigma and access barriers.